This study examines modifiable cardiovascular disease risk factors such as hypertension, dyslipidemia, and glucose intolerance/diabetes among adult survivors of childhood cancer. Awareness may mitigate these
Late cardiac complications after childhood cancer treatments remain high. This systematic review helps to provide a more detailed account of the frequency of heart failure
This resource outlines several promising preventive and treatment strategies for survivors at risk.
“Among young adult–aged survivors of childhood cancer, dexrazoxane was associated with a cardioprotective effect nearly 20 years after initial anthracycline exposure” — Eric J. Chow,
Despite being at higher risk for cardiovascular disease than the general population, young adults who had childhood cancer are less likely to be adequately treated
Childhood cancer survivors may be at increased risk of cardiac disease due to chemotherapy or chest-directed radiation. Primary prevention strategies may prove helpful, highlighting the
Most childhood cancer survivors do not develop heart problems, but the heart can be affected by certain types of cancer treatments. Since this can occur
Radiation to the chest and anthracyclines are the leading causes of cardiac late effects. Healthy habits such as physical activity and a heart-healthy diet can
The second childhood cancer-focused externally-led patient focused drug development workshop for the FDA spotlighted the burden of lifelong cardiac late effects in pediatric cancer survivors.
This resource details cardiac disease after treatment for childhood cancer: prevalence, risk factors, prevention, risk prediction, and surveillance.
